MedPath

Control of Colic in Infants by Dietary Supplementation With the Probiotic Lactobacillus Reuteri

Phase 4
Conditions
Colic
Registration Number
NCT01067027
Lead Sponsor
Children's Investigational Research Program, LLC
Brief Summary

It is believed that probiotic Lactobacillus reuteri will improve the symptoms of breast-fed infants with colic.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
50
Inclusion Criteria
  • Ifants aged between 14 and 60 days
  • Breast fed, exclusively during length of trial
  • Diagnosis of infantile colic according to Wessel's criteria i.e paroxysmal fussing in infancy for more than three hours per day, at least three days per week.
  • Debut of colic symptoms 6+/-1 days before randomization
  • Gestational age between 37 and 42 weeks
  • Apgar score higher than 7 at 5 minutes
  • Mothers willing to follow a cows mild-free diet (free from mild, yoghurt, cheese etc) during the study period
  • Written informed consent from one or both parents
  • Stated availability throughout the study period
Exclusion Criteria
  • Major chronic disease
  • Gastrointestinal disease but controlled GERD with or without medication is not an exclusion criteria
  • Administration of anitbiotics the week before randomization
  • Administration of probiotics the week before randomization
  • Participation in other clinical trials

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
* Reduction of daily average crying time to less than 3 hours from baseline to the end of the study period as measured using a daily reporting of crying time by the parents.7, 14 and 21 days
Secondary Outcome Measures
NameTimeMethod
Number of responders versus non-responders with L. reuteri versus placebo at end of the study.21 days

Trial Locations

Locations (1)

Children's Investigational Research Program

🇺🇸

Bentonville, Arkansas, United States

© Copyright 2025. All Rights Reserved by MedPath